The SPRR2A-CSTA axis drives IL-17A–induced squamous metaplasia and steroid resistance in allergic rhinitis
Journal of Allergy and Clinical Immunology · 2026-10 · 158 (4) · 994-1009.e8
DOI: 10.1016/j.jaci.2026.05.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-10. Verfasst von Shaobing Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Department of Otolaryngology Head and Neck S…. Hauptthemen laut MEDLINE: Cornified Envelope Proline-Rich Proteins, Interleukin-17, Rhinitis, Allergic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: Epithelial remodeling, particularly squamous metaplasia (SM), is a common but understudied epithelial alteration in refractory allergic rhinitis (AR). Its molecular drivers and contribution to steroid resistance remain unclear. OBJECTIVE: We sought to define the epithelial keratinization program underlying SM in AR and determine its role in glucocorticoid resistance. METHODS: Nasal mucosa tissues from patients with refractory AR with or without SM were assessed by immunostaining and transcriptomic profiling. Small proline-rich protein 2A (SPRR2A)-deficient mice were used to determine the role of SPRR2A in epithelial keratinization and steroid responsiveness. Primary nasal epithelial cells were stimulated with IL-17A or cystatin A (CSTA) to evaluate SPRR2A-dependent keratinization and steroid resistance. Serum SPRR2A and CSTA levels were quantified in patients with AR stratified by steroid responsiveness. RESULTS: Transcriptomic analysis identified SPRR2A as a leading epithelial marker associated with SM in AR. SPRR2A-associated keratin remodeling, including upregulation of KRT6A and KRT13, represented a defining molecular signature of SM. Glucocorticoid receptor β, a key mediator of steroid resistance, was markedly increased and colocalized with KRT6A and KRT13 in SM tissues. IL-17A induced a robust SPRR2A-keratin remodeling module, generating a steroid-resistant epithelial state. Genetic deletion of Sprr2a abolished IL-17A-driven keratinization, prevented SM, and restored steroid responsiveness. Mechanistically, CSTA emerged as a SPRR2A-dependent effector that promoted squamous differentiation and epithelial GRβ induction. Csta-treated primary cultures recapitulated SM and conferred steroid resistance. Clinically, elevated serum SPRR2A and CSTA levels distinguished patients with steroid-resistant AR from those with steroid-responsive AR. CONCLUSIONS: SPRR2A promotes epithelial SM and steroid resistance through CSTA, identifying the SPRR2A-CSTA axis as a potential therapeutic target and biomarker pathway in refractory AR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital of Central South University, Changsha, Hunan,…
- Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
- Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Department of Pediatric Respiratory Medicine, Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, China; Hunan Province Key Laboratory of Otolaryngology Critical Diseases, Xiangya Hospital of Central So…
- Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: pgao1@jhmi.edu.
Förderung
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Xie, S., Yuan, X., Liu, L., Wu, M., Gu, W., Zhang, H., Xie, Z., Jiang, W., & Gao, P. (2026). The SPRR2A-CSTA axis drives IL-17A–induced squamous metaplasia and steroid resistance in allergic rhinitis. Journal of Allergy and Clinical Immunology, 158(4), 994-1009.e8. https://doi.org/10.1016/j.jaci.2026.05.024
Vancouver
Xie S, Yuan X, Liu L, Wu M, Gu W, Zhang H, et al. The SPRR2A-CSTA axis drives IL-17A–induced squamous metaplasia and steroid resistance in allergic rhinitis. Journal of Allergy and Clinical Immunology. 2026;158(4):994-1009.e8. doi:10.1016/j.jaci.2026.05.024
BibTeX
@article{Xie2026,
author = {Xie, Shaobing and Yuan, Xuan and Liu, Liyuan and Wu, Maonan and Gu, Wenjing and Zhang, Hua and Xie, Zhihai and Jiang, Weihong and Gao, Peisong},
title = {The SPRR2A-CSTA axis drives IL-17A–induced squamous metaplasia and steroid resistance in allergic rhinitis},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
volume = {158},
number = {4},
pages = {994--1009.e8},
doi = {10.1016/j.jaci.2026.05.024}
}
EUVIMED